Cancer Research Fund Of The Damon Runyon-Walter Winchell Foundation
- Assets
- $147.7m
- Revenue
- $15.7m
- Investments
- $8.4m
- Employees
- 21
- Location
- New York, NY
- Founding
- 06/1947
- Data as of
- 06/2023
- EIN
- 13-1933825
Organization Overview
Cancer Research Fund Of The Damon Runyon-Walter Winchell Foundation is located in New York, NY. The organization was established in 1947. According to its NTEE Classification (E12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Health Care and related organizations. As of 06/2023, Cancer Research Fund Of The Damon Runyon-Walter Winchell Foundation employed 21 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Cancer Research Fund Of The Damon Runyon-Walter Winchell Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2023, Cancer Research Fund Of The Damon Runyon-Walter Winchell Foundation generated $15.7m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 3.2% each year. All expenses for the organization totaled $21.2m during the year ending 06/2023. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
ACCELERATING BREAKTHROUGHS BY FUNDING THE MOST INNOVATIVE YOUNG CANCER RESEARCHERS
Describe the Organization's Program Activity:
Part 3 - Line 4a
FELLOWSHIP AWARDS: SUPPORTS THE TRAINING OF THE BRIGHTEST POSTDOCTORAL SCIENTISTS AS THEY EMBARK UPON THEIR RESEARCH CAREERS. THIS FUNDING ENABLES THEM TO BE TRAINED BY ESTABLISHED INVESTIGATORS IN LEADING RESEARCH LABORATORIES ACROSS THE COUNTRY, WHILE INDEPENDENTLY CONDUCTING LEADING-EDGE SCIENCE THAT WILL BRING NEW UNDERSTANDING AND CURES FOR CANCER.
CLINICAL INVESTIGATOR AWARDS: SUPPORTS EARLY CAREER PHYSICIAN-SCIENTISTS CONDUCTING PATIENT-ORIENTED RESEARCH. THE GOAL OF THIS PROGRAM IS TO INCREASE THE NUMBER OF PHYSICIANS CAPABLE OF MOVING SEAMLESSLY BETWEEN THE LABORATORY AND THE PATIENT'S BEDSIDE IN SEARCH OF BREAKTHROUGH TREATMENTS.
RACHLEFF INNOVATION AWARDS: SUPPORTS THE NEXT GENERATION OF EXCEPTIONALLY CREATIVE THINKERS WITH "HIGH RISK/HIGH REWARD" IDEAS THAT HAVE THE POTENTIAL TO SIGNIFICANTLY IMPACT OUR UNDERSTANDING OF AND/OR APPROACHES TO THE PREVENTION, DIAGNOSIS OR TREATMENT OF CANCER, BUT LACK SUFFICIENT PRELIMINARY DATA TO OBTAIN TRADITIONAL FUNDING.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Deborah J Coleman Chair | OfficerTrustee | 1 | $0 |
William G Kaelin Jr MD Vice Chair, Scientific Programs | OfficerTrustee | 1 | $0 |
Michael L Gordon Vice Chair, Board Development | OfficerTrustee | 1 | $0 |
David G Marshall Vice Chair, Investments & Treasurer | OfficerTrustee | 1 | $0 |
Sanford W Morhouse ESQ Vice Chair, Audit & Secretary | OfficerTrustee | 1 | $0 |
David M Beirne Vice Chair | Trustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Bouchezpage Production Management | 6/29/23 | $110,725 |
Rsm Us Llp Accounting Services | 6/29/23 | $171,445 |
Craft & Commerce Marketing | 6/29/23 | $195,750 |
Jp Morgan Investment Advisory | 6/29/23 | $156,029 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $1,369,363 |
| Related organizations | $0 |
| Government grants | $470,064 |
| All other contributions, gifts, grants, and similar amounts not included above | $7,316,400 |
| Noncash contributions included in lines 1a–1f | $516,436 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $9,155,827 |
| Total Program Service Revenue | $0 |
| Investment income | $2,483,969 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $355,606 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $3,794,223 |
| Net Income from Fundraising Events | -$318,555 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $15,715,675 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $16,245,786 |
| Grants and other assistance to Foreign Orgs/Individuals | $375,500 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $550,008 |
| Compensation of current officers, directors, key employees. | $107,506 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $1,635,863 |
| Pension plan accruals and contributions | $148,682 |
| Other employee benefits | $275,355 |
| Payroll taxes | $132,967 |
| Fees for services: Management | $945 |
| Fees for services: Legal | $13,369 |
| Fees for services: Accounting | $188,735 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $137,859 |
| Fees for services: Other | $275,655 |
| Advertising and promotion | $128,683 |
| Office expenses | $64,059 |
| Information technology | $128,715 |
| Royalties | $0 |
| Occupancy | $351,322 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $99,821 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $31,775 |
| Insurance | $46,882 |
| All other expenses | $21,290 |
| Total functional expenses | $21,219,216 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $147,903 |
| Savings and temporary cash investments | $5,915,458 |
| Pledges and grants receivable | $5,982,502 |
| Accounts receivable, net | $296,671 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $179,381 |
| Net Land, buildings, and equipment | $135,325 |
| Investments—publicly traded securities | $117,972,979 |
| Investments—other securities | $8,365,504 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $8,684,964 |
| Total assets | $147,680,687 |
| Accounts payable and accrued expenses | $385,596 |
| Grants payable | $29,506,447 |
| Deferred revenue | $937,917 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $2,091,012 |
| Total liabilities | $32,920,972 |
| Net assets without donor restrictions | $97,419,092 |
| Net assets with donor restrictions | $17,340,623 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $147,680,687 |